Navigation Links
Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology
Date:10/24/2008

- Technology In-Licensed by Stem Cell Sciences From University of Cambridge

- ("Stem Cell Sciences", "SCS", "the Company")

CAMBRIDGE, England, Oct. 24 /PRNewswire/ -- Stem Cell Sciences plc (AIM: STEM, ASX: STC), a company focused on the commercialisation of stem cells and stem cell technologies, notes that a paper describing a technique for reprogramming adult mammalian cells into authentic induced pluripotent stem (iPS) cells has been published in PLoS Biology, the peer-reviewed scientific journal from the Public Library of Science (PLoS)(1). This rapid and reliable new approach for generating pluripotent stem cells without using mammalian embryos uses the combination of chemical inhibitors in SCS' Culticell iSTEM(TM) media range to overcome serious limitations in current approaches for producing such cells. Induced pluripotent stem cells are expected to have enormous potential in medical research, drug discovery and for the development of cell-based therapies.

The newly described technique, which was developed by Professor Austin Smith and his team at the University of Cambridge, features a key proprietary step that forms the basis of a licence agreement signed recently between SCS and Cambridge Enterprise, the technology transfer company for the University of Cambridge. The licence is a significant addition to SCS' strong portfolio of intellectual property around the development and commercialisation of stem cell technologies.

The key step as described in the PLoS publication for this rapid and new approach for making iPS cells occurs at the transition point between incomplete and complete reprogramming to pluripotency. Previous studies have indicated that progression through the transition point had been notoriously inefficient, but now via the use of chemical inhibitors (of the enzymes MEK and GSK3) in combination with the cell growth promoter, leukemia inhibitory factor (LIF), the inefficient process has been dramatica
'/>"/>

SOURCE Stem Cell Sciences plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
2. Stenting Techniques Vie in Branchpoint Lesions
3. Improved Cornea Surgery Technique Provides Enhanced Transplant Success
4. Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
5. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
6. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
7. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
8. Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs
9. Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma
10. New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation
11. Study Shows Benefits of a High Omega-3 Diet in Older Adults

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,N.J.,Nov.25/PRNewswire/--RegadoBiosciences,apriva...icaptamerswithactivecontrolagents,announcedthatDav...iperJaffray21stAnnualHealthCareConferenceattheNewY...willbegivenat1:10pm(EST)onTuesday,December1andwill...sontheleaddevelopmentprogram,theanticoagulantsyste...
(Date:11/25/2009)...K,N.J.,Nov.25/PRNewswire/--SwissrayInternational,I... ddR )systems,announcedtodaythatitsoperationshaveb...wtowardsgrowingSwissray,smedicalimagingbrand.Theac...aswellascontractsandinventory.After25yearsofsucces...ftechnologicaladvancementswithstableandsteadygrowt...
(Date:11/25/2009)...25/PRNewswire/--Reportlinker.comannouncesthatanewm..., IntranasalDrugDelivery-USMarketTrends&Analy...al-Drug-Delivery---US-Market-Trends--Analysis.html...inganexpansionoftherapeuticapplicationsfromthedeli...ryofsystemictherapeuticdrugs.Thefutureofthetechnol...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5IntelliSoft Group and Amerinet Inc Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 61876 1IntelliSoft Group and Amerinet Inc Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 61876 2New Haven Dental Group Expands Their Vision 61872 1New Haven Dental Group Expands Their Vision 61872 2Actuaries to Senate 3A Strengthen Individual Mandate 61868 1Actuaries to Senate 3A Strengthen Individual Mandate 61868 2
...1 In a boost to,HIV prevention research, Merck & ...cense to the non-profit International Partnership ...oviral compound for use as a,potential vaginal mic...r of a class of antiretroviral,molecules known as ...n by,preventing the virus from fusing with the sur...
...of MA-17 trial data provides evidence for, poten...after finishing tamo... class with data demonstrating this potential ben..., - Half of all breast cancer recurrences occur ... diagnosis, - Separate analysis published in ...
Other Medicine Technology:Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 2Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 2VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 4VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 5VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 6VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 7
(Date:11/25/2009)...RNewswire/--TheBartleHallConventionCenterwilltempo...-10,whenKansasCityhoststhelatestinaseriesofmassive...iceventhasthepotentialtobethebiggestoneyet,because...weekdaysinsteadofoveraweekend,"SheriWood,executive...toftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...re/-SentinelleMedicalInc.,aleadingmanufacturerofbr...esasuiteofnewleadingedgeclinicalapplicationsonitsA...RadiologicalSocietyofNorthAmerica(RSNA)annualmeeti...applicationsleveragetheuniquehighqualityimagesgene...pportmultipleimagingmodalitiesformulti-parametrica...
(Date:11/25/2009)...swire-USNewswire/--TheBlackAIDSInstituterecentlyhe...ershipfor2010. ,, ThenewBoardMembersareahighlyd...law,finance,governmenthealthprograms,editorial,and...erangeofpersonalbackgroundsincludingbothheterosexu...es,andrepresentingmultipleagegroups. ,, (Photo:...
(Date:11/25/2009)...ular cancer who were treated with cisplatin-based ...ng neurological side effects and Raynaud-like phen...rapy, according to a new study published online No...nstitute . , Marianne Brydy, M.D., of the Depart...n Bergen, Norway, and colleagues conducted a cross...
(Date:11/25/2009)...essure? This simple question has been the focus o...ated gene Modulates High Blood Pressure in Mice & ...imple question has been the focus of intense resea...first time established a link between a novel gene...ress in mice as well as humans. The studies were d...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
... at reducing problems in heart transplant patients...y the drug reduced the incidence of a serious diso...wn as coronary vasculopathy.// Previous studi... University in Philadelphia conducted a study to d...
...nerable to serious brain injuries when they fall t...tigators distinguish between accidental and intent...a study found that rotational forces generated by ...issue and alter brain function, and nerve cell dam...
...ly common procedure for hard-to-treat cancers. The...take months or even years for stem cells// to beco...is at risk for serious infection. Now, researchers...experimental treatment. In Ed Bauters case...
...t sperm as they get older //and they found to thei...perm an edge. The deformed sperm increase the r...less are likely to beat out their healthy counterp...e is more common in children born to older fathers...
...thma attacks be causing the very thing it aims to ... School of Public Health and Brigham and Women’s H...wn as beta-agonists in asthmatics. Beta-ago...pill or liquid form, delivered in a nebulizer, or ...
...ath rate from it is falling due to early detection...versity of Southern Denmark carried out an analysi...ween 1993 and 1999. While the proportion of pe...Commenting on the findings published in this week'...
Other Medicine News:
Alkaline Phosphatase
Uric Acid (Uricase) (Single Reagent)
Uric acid FS TBHBA
Uric Acid
Medicine Products: